These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15222110)
1. [Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response]. Yoshida T; Horiguchi J; Koibuchi Y; Kanoh T; Iijima K; Yoshida M; Kikuchi M; Takata D; Oyama T; Iino Y; Morishita Y Gan To Kagaku Ryoho; 2004 Jun; 31(6):907-10. PubMed ID: 15222110 [TBL] [Abstract][Full Text] [Related]
2. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment]. Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029 [TBL] [Abstract][Full Text] [Related]
3. [Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases]. Rai Y; Takahama T; Sagara Y; Sagara Y; Matsuyama Y; Ando M; Sagara Y; Ooi Y Gan To Kagaku Ryoho; 2006 Sep; 33(9):1297-300. PubMed ID: 16969028 [TBL] [Abstract][Full Text] [Related]
4. [Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response]. Rai Y; Sagara Y; Sagara Y; Takahama T; Matsuyama Y; Ando M; Sagara Y; Ooi Y; Inoue K; Kurosumi M Gan To Kagaku Ryoho; 2007 Jan; 34(1):65-8. PubMed ID: 17220672 [TBL] [Abstract][Full Text] [Related]
5. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report]. Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023 [TBL] [Abstract][Full Text] [Related]
6. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer. Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474 [TBL] [Abstract][Full Text] [Related]
7. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases]. Tohnosu N; Kobayashi Y; Saito T; Shimizu T; Natsume T; Tanaka H; Maruyama T; Watanabe Y Gan To Kagaku Ryoho; 2003 Jul; 30(7):989-92. PubMed ID: 12894716 [TBL] [Abstract][Full Text] [Related]
8. A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment. Hayashi H; Kimura M; Yoshimoto N; Tsuzuki M; Tsunoda N; Fujita T; Yamashita T; Iwata H Breast Cancer; 2009; 16(2):136-40. PubMed ID: 18548321 [TBL] [Abstract][Full Text] [Related]
9. [A case of HER2 overexpressing recurrent breast cancer treated clinically showing a complete response to trastuzumab/paclitaxel combination therapy]. Mizuno Y; Chin K; Ando N; Oike E Gan To Kagaku Ryoho; 2006 Sep; 33(9):1293-6. PubMed ID: 16969027 [TBL] [Abstract][Full Text] [Related]
10. [Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response]. Rai Y; Sagara Y; Ooi Y; Sagara Y; Sagara Y; Baba S; Tamada S; Matsuyama Y; Ando M Gan To Kagaku Ryoho; 2009 Mar; 36(3):471-3. PubMed ID: 19295274 [TBL] [Abstract][Full Text] [Related]
11. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer]. Tsubota Y; Sueoka N; Yamamoto D Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer. Burris H; Yardley D; Jones S; Houston G; Broome C; Thompson D; Greco FA; White M; Hainsworth J J Clin Oncol; 2004 May; 22(9):1621-9. PubMed ID: 15117984 [TBL] [Abstract][Full Text] [Related]
13. A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment. Shigematsu H; Nakamura Y; Tanaka K; Shiotani S; Koga C; Kawaguchi H; Nishimura S; Taguchi K; Nishiyama K; Ohno S Int J Clin Oncol; 2010 Dec; 15(6):615-20. PubMed ID: 20473628 [TBL] [Abstract][Full Text] [Related]
14. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups. Untch M; Fasching PA; Konecny GE; Hasmüller S; Lebeau A; Kreienberg R; Camara O; Müller V; du Bois A; Kühn T; Stickeler E; Harbeck N; Höss C; Kahlert S; Beck T; Fett W; Mehta KM; von Minckwitz G; Loibl S J Clin Oncol; 2011 Sep; 29(25):3351-7. PubMed ID: 21788566 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment with weekly paclitaxel and carboplatin combined with trastuzumab in a patient with heavily pretreated metastatic breast cancer. Kikuchi Y; Takano M; Kudoh K; Kita T; Sato K Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):189-91. PubMed ID: 18778887 [No Abstract] [Full Text] [Related]
16. [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab]. Nakajima H; Mizuta N; Mizuta M; Nakatsukasa K; Kobayashi A; Hachimine Y; Sakaguchi K; Fujiwara I; Sawai K Gan To Kagaku Ryoho; 2006 Sep; 33(9):1305-8. PubMed ID: 16969030 [TBL] [Abstract][Full Text] [Related]
17. [Two cases of effective weekly paclitaxel administration for metastatic breast cancer]. Kokufu I; Taniguchi H; Kim Y; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H Gan To Kagaku Ryoho; 2001 Nov; 28(12):1905-8. PubMed ID: 11729485 [TBL] [Abstract][Full Text] [Related]
18. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840 [TBL] [Abstract][Full Text] [Related]
19. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients]. Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471 [TBL] [Abstract][Full Text] [Related]
20. Pathological complete response to trastuzumab and paclitaxel in a patient with inflammatory local recurrence following breast conserving surgery. Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S; Ohshima M Breast Cancer; 2005; 12(3):226-30. PubMed ID: 16110294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]